Uncommon
United Kingdom
- Cambridge, England
- 12/06/2023
- Series A
- $30,000,000
Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering.
Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the health of consumers.
We’ve raised capital totalling $37M from Balderton, Lowercarbon Capital, RedAlpine, Sam Altman (Open AI founder) and Max Altman as well as the UK government through a $1.2M Innovate UK grant.
From the cell to the sizzle, our Uncommon Bacon and Uncommon Belly are packed full of nutritious goodness and fantastic flavour; paving the way for an Uncommonly good future of delicious, healthy and sustainable meat.
Unleash your creativity and join us!
- Industry Biotechnology Research
- Website https://uncommonbio.co/
- LinkedIn https://www.linkedin.com/company/uncommonbio/
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)